Subtype
Uterine Corpus Neoplasm
CI-CAN-00007035Explore in graph →
Non-malignant451 active trials4 approved drugs28 evidence items
- NCIt
- C6300
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007035Explore in graph →
Clinical trials
1,714 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003669 | Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer | completed | Phase 2 | — | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00004915 | Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00032162 |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer |
| completed |
| Phase 1 / Phase 2 |
| 63 |
| AGO Study GroupOTHER |
| 1 |
| May 31, 2012 |
| clinicaltrials |
| NCT00333086 | A Study of Letrozole in the Treatment of Endometrial Cancer | completed | Phase 2 | 36 | Novartis PharmaceuticalsINDUSTRY | 1 | Apr 19, 2012 | clinicaltrials |
| NCT00607607 | A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer | completed | Phase 2 | 44 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00569257 | Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors | completed | Phase 2 | 85 | AEterna ZentarisINDUSTRY | 2 | Dec 13, 2011 | clinicaltrials |
| NCT00776074 | A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. | completed | Phase 2 | 80 | TakedaINDUSTRY | 0 | Jun 22, 2010 | clinicaltrials |
| NCT00249990 | Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC) | completed | Phase 2 | 39 | University of New MexicoOTHER | 1 | Jan 7, 2010 | clinicaltrials |
| NCT00377520 | A Trial for Patients With Advanced/Recurrent Endometrial Cancer | completed | Phase 2 | 27 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00712595 | Mifepristone for Treatment of Uterine Fibroids(Mifemyo) | completed | Phase 2 / Phase 3 | 200 | Mediterranea Medica S. L.OTHER | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00150644 | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy | completed | Phase 2 | 33 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00612495 | Endometrial Cancer - LOHP Alone and With 5FU | completed | Phase 2 | 31 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00401635 | END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin | completed | Phase 2 | 42 | National Cancer Institute, NaplesOTHER | 1 | Sep 5, 2007 | clinicaltrials |
| NCT00010829 | Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Aug 18, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Jun 7, 2012source: clinicaltrials